Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy

In locally advanced intrahepatic cholangiocarcinoma, hepatic artery infusion with floxuridine in combination with systemic therapy can offer long-term durable disease control. Molecular alterations may predict for response.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2024-09-27
DOI
https://doi.org/10.1093/jnci/djae202
Citations
5
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
2.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy

Alice C. Wei, Darren Cowzer, Michael I. D’Angelica, Henry S. Walch et al.
5 citations
JNCI Journal of the National Cancer Institute
Cholangiocarcinoma and Gallbladder Cancer Studies
2.86
article

Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy

Alice C. Wei, Darren Cowzer, Michael I. D’Angelica, Henry S. Walch, Louise C. Connell, Francisco Sánchez-Vega, Anna M. Varghese, Andrea Cercek, Diane Reidy‐Lagunes, Nikolaus Schultz, Leonard B. Saltz, William R. Jarnagin, Mithat Gönen, Richard Kinh Gian, Kevin C. Soares, Vinod P. Balachandran, James J. Harding, Nancy E. Kemeny, T. Peter Kingham, Jeffrey A. Drebin, Ghassan K. Abou‐Alfa, Taryn Boucher
article en
5 citations

Abstract

In locally advanced intrahepatic cholangiocarcinoma, hepatic artery infusion with floxuridine in combination with systemic therapy can offer long-term durable disease control. Molecular alterations may predict for response.

JNCI Journal of the National Cancer InstituteVol. 117(2)
Memorial Sloan Kettering Cancer Center (US), Trinity College Dublin (IE), Cornell University (US)
National Institutes of Health, National Cancer Institute
Openalex Percentile: Top 9%
Cholangiocarcinoma and Gallbladder Cancer Studies
2.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.